Previous Close | 0.7500 |
Open | 0.7500 |
Bid | 0.0000 |
Ask | 2.0000 |
Strike | 35.00 |
Expire Date | 2024-06-21 |
Day's Range | 0.7500 - 0.7500 |
Contract Range | N/A |
Volume | |
Open Interest | 347 |
Investors need to pay close attention to Supernus (SUPN) stock based on the movements in the options market lately.
SPN-817 is a novel, first-in-class highly selective acetylcholinesterase (AChE) inhibitor for epilepsy Company to host webcast today at 4:30 p.m. ET to discuss the interim data ROCKVILLE, Md., May 23, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced data from the planned interim analysis of the exploratory open-label Pha
Despite Challenges, Company Shows Promising Growth in Key Areas